Akebia Therapeutics
AKBA
AKBA
143 hedge funds and large institutions have $294M invested in Akebia Therapeutics in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less funds holding
Funds holding: 164 → 143 (-21)
55% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 38
Holders
143
Holding in Top 10
1
Calls
$6.42M
Puts
$2.35M
Top Buyers
| 1 | +$20.8M | |
| 2 | +$13.6M | |
| 3 | +$6.28M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.46M |
| 5 |
Renaissance Technologies
New York
|
+$4.02M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$14.2M | |
| 3 | -$8.98M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$4.99M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.71M |